A pituitary microadenoma is a benign tumor in the pituitary gland that measures less than 10 millimeters across. These small growths are surprisingly common, found in roughly 10.7% of people in autopsy studies and about 3.4% on MRI scans, meaning millions of people have one without ever knowing it. Most pituitary microadenomas never cause problems, but some produce excess hormones that can affect fertility, metabolism, and overall health.
Where It Grows and Why It Matters
The pituitary gland sits at the base of the brain, nestled in a small bony pocket behind the bridge of your nose. Despite being about the size of a pea, it controls a wide range of hormonal functions: growth, thyroid activity, stress response, reproduction, and milk production. A microadenoma grows from the cells of this gland. Because of its small size (under 10mm), it almost never presses on surrounding structures like the optic nerves, which is a key difference from its larger counterpart, the macroadenoma (10mm or larger).
These tumors are benign, meaning they don’t spread to other parts of the body. The main concern isn’t the tumor itself but whether it’s pumping out extra hormones that throw your body off balance.
Functioning vs. Non-Functioning Types
Pituitary microadenomas fall into two broad categories based on whether they produce hormones.
Non-functioning microadenomas don’t secrete hormones in clinically meaningful amounts. They represent somewhere between 22% and 54% of all pituitary adenomas, depending on the study. Many are discovered incidentally when someone gets a brain MRI for an unrelated reason, like a headache or head injury. These “incidentalomas” often require nothing more than periodic monitoring.
Functioning microadenomas actively secrete one or more hormones. The type of hormone produced depends on which pituitary cells the tumor arose from:
- Prolactinomas produce prolactin and are the most common functioning type.
- Growth hormone-secreting tumors cause a condition called acromegaly, leading to gradual enlargement of the hands, feet, and facial features.
- ACTH-secreting tumors trigger Cushing’s disease by driving excess cortisol production. These tend to be very small and are notoriously difficult to detect on imaging.
- TSH-secreting tumors overstimulate the thyroid, causing hyperthyroidism.
- Gonadotropin-secreting tumors produce reproductive hormones (FSH or LH), though these rarely cause obvious symptoms at the microadenoma stage.
Symptoms Depend on the Hormone Involved
A non-functioning microadenoma typically causes no symptoms at all. When symptoms do appear, they’re driven by whichever hormone the tumor is overproducing.
Prolactinomas are the clearest example. In women, excess prolactin commonly causes irregular or missed periods, difficulty getting pregnant, and sometimes milky discharge from the breasts unrelated to nursing. In men, the same hormone excess leads to decreased sex drive, erectile dysfunction, and reduced sperm production. Both men and women may experience bone thinning, fatigue, anxiety, depression, and emotional instability from chronically elevated prolactin.
ACTH-secreting microadenomas produce a different picture entirely. Excess cortisol leads to weight gain concentrated in the face and midsection, thinning skin that bruises easily, muscle weakness, high blood sugar, and mood changes. Growth hormone-secreting tumors cause gradual changes that may take years to notice, including thickening of the fingers, coarsened facial features, joint pain, and excessive sweating.
How Microadenomas Are Found
MRI is the primary tool for detecting pituitary microadenomas. A standard pituitary MRI protocol includes images taken in multiple planes, both before and after injecting a contrast agent into a vein. The contrast highlights differences in how quickly blood flows through normal pituitary tissue versus tumor tissue. Dynamic imaging, where a series of scans are captured at intervals over roughly three minutes after contrast injection, is particularly useful for spotting tiny tumors that might otherwise blend in with surrounding tissue.
Even with these techniques, some microadenomas are hard to see. ACTH-secreting tumors are especially challenging because they tend to have signal and contrast-enhancement patterns very similar to normal pituitary tissue. Standard MRI detects only about 60% of these tumors. When blood tests strongly suggest Cushing’s disease but the MRI looks normal, additional testing or specialized imaging protocols may be needed.
Blood work plays an equally important role. Hormone levels in the blood confirm whether a visible tumor is functioning and, if so, which hormone it’s producing. For suspected prolactinomas, a simple prolactin blood test is often enough. For Cushing’s disease or acromegaly, the testing is more involved and may require multiple samples collected at different times of day or after specific stimulation tests.
Treatment Varies by Tumor Type
The approach to treatment depends almost entirely on whether the microadenoma is producing hormones and, if so, which ones.
Non-Functioning Microadenomas
Most non-functioning microadenomas don’t need treatment. The standard approach is surveillance with repeat MRI, typically 2 to 3 years after the initial scan. If the tumor remains stable in size over time, the interval between scans can be lengthened. Periodic hormone testing ensures the tumor isn’t quietly affecting pituitary function. Many people with these incidental findings live their entire lives without the tumor ever growing or causing symptoms.
Prolactinomas
Prolactinomas are one of the few tumor types in the body that respond well to medication instead of surgery. Dopamine agonists, a class of drugs that mimics the brain chemical dopamine, can shrink prolactinomas and bring prolactin levels back to normal in most patients. These medications are taken as tablets, typically once or twice a week. For many people, this means symptoms like irregular periods or low libido resolve within weeks to months of starting treatment.
Surgery for Other Functioning Tumors
Surgery is the preferred treatment for microadenomas that cause Cushing’s disease or acromegaly, since these tumor types don’t respond as reliably to medication alone. The most common procedure is transsphenoidal surgery, where the surgeon reaches the pituitary through the nasal passages and sinuses without needing to open the skull. This approach has a high success rate for microadenomas, and most patients recover within a few weeks. Surgery is also recommended when a prolactinoma doesn’t respond to medication or when a functioning tumor is causing infertility that a patient wants to resolve.
For acromegaly, dopamine agonists are sometimes tried as a first-line or add-on therapy, but results are only moderate. Higher doses are often needed, and many patients ultimately require surgery or other medications to control growth hormone levels.
Long-Term Outlook and Monitoring
The prognosis for pituitary microadenomas is generally excellent. Non-functioning microadenomas grow slowly, if at all, and serious complications are rare at this size. Pituitary apoplexy, a sudden bleed into the tumor that causes severe headache and vision changes, occurs almost exclusively in macroadenomas and has rarely been reported in microadenomas.
For functioning microadenomas, outcomes depend on achieving hormonal control. Prolactinomas managed with medication have remission rates high enough that some patients can eventually taper off treatment under medical supervision. Cushing’s disease and acromegaly require closer follow-up even after successful surgery, since recurrence is possible years later. Regular endocrinology visits with periodic hormone checks and imaging are the backbone of long-term care for any pituitary adenoma, whether it was treated or simply watched.